Neuronetics Inc. (STIM): Kapitalisasi marang pendapatan
Low geopolitical risks ensure stable sales across developed countries. Consistent demand for services and consumables for installed systems creates predictable revenue. The capitalization-to-sales ratio reflects the market's reaction to news, with the value holding at 0.70. Neuronetics, Inc. (STIM) leads the TMS segment, offering psychiatrists the NeuroStar system for drug-free depression treatment.
Rincian analitis perusahaan NeuroStar (STIM)
- rega saham lan konsensus proyeksi valuasi:
- data kapitalisasi bursa:
- indikator nilai buku ekuitas:
- statistik kawajiban utang lan likuiditas:
Koefisien Total Utang marang Modal Neuronetics, Inc.|STIM - Utang jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas Neuronetics, Inc|STIM - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku NeuroStar|STIM - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Neuronetics|Rasio jangkoan perantara neurostar.com
- data bathi lan kelipatan valuasi:
STIM - Bathi resik|Bathi resik sing dikarepake Neuronetics, Inc.|STIM - Rasio rega marang bathi|Pangali forward rega marang bathi Neuronetics Inc.|STIM - Pangali rega marang bathi tumrap wutah|Pangali EV/EBITDA NeuroStar|STIM - Bathi operasional EBITDA|Bathi resik saben saham sajrone patang kuartal pungkasan Neuronetics|STIM - Bathi saben saham sajrone rolas wulan pungkasan|Dinamika bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan neurostar.com|STIM - Wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep Neuronetics, Inc.
- rincian pendapatan lan dodolan emiten:
Analisis umum perusahaan:STIM neurostar.com
To qualitatively assess an asset, an investor analyzes the company's price-to-sales ratio, which determines the market price of each unit of sales and signals whether the business is overbought or undervalued. This chart reflects market expectations regarding the expansion of Neuronetics, Inc. (STIM), where a rising multiple confirms capital's confidence in the success of the new strategy to expand insurance coverage for brain stimulation systems.
Pesaing Neuronetics, Inc.
BSX (bostonscientific.com) - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Edwards Lifesciences Corporation EW|RMD - Kapitalisasi marang pendapatan|OmniPod - Multiplikator P/S|Rega marang dodolan Zimmer Biomet Holdings|COO: Multiplikator P/S|Rasio kapitalisasi marang pendapatan ALGN|GMED (Globus Medical) - Multiplikator P/S|TransMedics Group Inc (TMDX) - Koefisien rega marang pendapatan|Multiplikator P/S ATEC|Kapitalisasi marang pendapatan Artivion Corp AORT|Multiplikator P/S ENOV (Enovis Corporation)|Multiplikator P/S integralife.com IART|ESTA - Rasio rega marang pendapatan|BBNX: Rasio rega marang pendapatan|IRMD (Iradimed) - Kapitalisasi marang pendapatan|Embecta Health - Rasio kapitalisasi pasar marang pendapatan|TNDM (Tandem Diabetes Care) - Multiplikator P/S|Rega marang dodolan axogeninc.com AXGN|Rasio rega marang pendapatan SI-BONE (SIBN)|Orthofix Medical (OFIX) - Multiplikator rega marang pendapatan|Bioventus Corp - Kapitalisasi marang pendapatan|Multiplikator P/S OrthoPediatrics Corp KIDS|Treace Medical Concepts - Multiplikator P/S|Koefisien rega marang pendapatan blade.com SRTA|Carlsmed (CARL) - Rasio rega marang pendapatan|Rasio rega marang dodolan RXST (RxSight Inc)|Rasio rega marang pendapatan ClearPoint Neuro Inc.|Kapitalisasi marang pendapatan Stereotaxis Corporation (STXS)|Multiplikator P/S SGHT|OBIO - Rega marang dodolan|Rasio rega marang pendapatan Anika Therapeutics, Inc. ANIK|NSPR: Rasio kapitalisasi marang pendapatan|ZJYL: Kapitalisasi marang pendapatan|Vivani Medical, Inc. - Kapitalisasi marang volume dodolan|xtantmedical.com (XTNT) - Rasio rega marang pendapatan|Rasio kapitalisasi marang pendapatan NMTC|MODD (Modular Medical Inc) - Multiplikator P/S|Rega marang dodolan Myomo Inc. MYO|Kapitalisasi marang pendapatan COCH (Envoy Medical, Inc)|Multiplikator P/S Vivos Therapeutics Inc (VVOS)|Rasio rega marang pendapatan enVVeno Medical NVNO|Rasio kapitalisasi pasar marang pendapatan SINT|TNON - Rasio rega marang pendapatan|Rega marang dodolan ReWalk Robotics|autonomix.com (AMIX) - Rasio rega marang pendapatan|Rasio kapitalisasi marang pendapatan IVF|BBLG (Bone Biologics) - Multiplikator P/S|Rega marang dodolan axonics.com AXNX|Kapitalisasi marang pendapatan BIOL (BIOLASE)|Kapitalisasi marang volume dodolan DYNT|Multiplikator P/S FNA (Paragon 28)|Koefisien rega marang pendapatan INVO Bioscience Inc. (INVO)
